Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer

CONCLUSION: First-line ICIs plus chemotherapy should be applied in clinical practice. If patients did not use ICIs plus chemotherapy in first-line therapy, the use of ICIs in the second line or subsequent lines of treatment could prolong PFS2.PMID:38598001 | DOI:10.1007/s12094-024-03471-y

Source: Clinical Lung Cancer - April 10, 2024 Category: Cancer & Oncology Authors: Song Mi Yunxin Yang Xin Liu Shaotong Tang Ning Liang Jinyue Sun Chao Liu Qidong Ren Jihong Lu Pingping Hu Jiandong Zhang Source Type: research